Cingulate (CINGW) Accounts Payables (2021 - 2026)
Cingulate's (CINGW) quarterly Accounts Payables came in at $2.0 million in Q2 2026, down 2.45% quarter-over-quarter from $2.0 million in Q4 2025.
Analysis
Cingulate (CINGW) Accounts Payables (2021 - 2026) Analysis & Trends
Cingulate (CINGW) has reported Accounts Payables for 6 consecutive years, with $2.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Accounts Payables changed N/A year-over-year to $2.0 million; the trailing twelve-month figure through Jun 2026 stood at $2.0 million (changed N/A YoY), and the FY2025 full-year result was $2.0 million, up 60.25% from the prior year.
- Accounts Payables slipped to $2.0 million in Q2 2026 per CINGW's latest filing, from $2.0 million in the prior quarter.
- Across five years, Accounts Payables topped out at $5.2 million in Q4 2023 and bottomed at $282265.0 in Q2 2022.
- Historically, Accounts Payables has averaged $1.3 million across 5 years, with a median of $886230.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Accounts Payables soared 581.98% in 2023, then tumbled 75.57% in 2024.
- Over 5 years, Accounts Payables stood at $762357.0 in 2022, then jumped by 581.98% to $5.2 million in 2023, then sank by 75.57% to $1.3 million in 2024, then jumped by 60.25% to $2.0 million in 2025, then decreased by 2.45% to $2.0 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $2.0 million, $2.0 million, and $866245.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.46 Bn | 623.70 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 440.11 Bn | 433.54 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 365.04 Bn | 357.90 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | 4.58 Bn |
| 6 | Sanofi | 52.47 Bn | 45.09 Bn | 10.79 Bn | 8.31 Bn |
| 7 | Revolution Medicines | 44.26 Bn | 44.26 Bn | - | 88.42 Mn |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 250.40 Mn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 497.80 Mn |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | 1.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.99 Mn |
| Dec 31, 2025 | 2.04 Mn |
| Sep 30, 2025 | 866,245.00 |
| Mar 31, 2025 | 855,150.00 |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 906,215.00 |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 737,949.00 |
| Dec 31, 2023 | 5.20 Mn |
| Sep 30, 2023 | 1.67 Mn |
| Jun 30, 2023 | 1.61 Mn |
| Mar 31, 2023 | 599,033.00 |
| Dec 31, 2022 | 762,357.00 |
| Sep 30, 2022 | 392,798.00 |
| Jun 30, 2022 | 282,265.00 |
| Mar 31, 2022 | 556,326.00 |
| Dec 31, 2021 | 264,687.00 |